Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenias Hwenda

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Lancet. Global Health|June 17, 2022
The business case for vaccine and drug manufacturing in middle-income countriesLenias Hwenda
Lancet (London, England)|November 15, 2011
The remaining smallpox stocks: the wrong debate?Lenias Hwenda, Bjørn-Inge Larsen
The Lancet. Global Health|April 20, 2020
COVID-19: time to plan for prompt universal access to diagnostics and treatmentsLuca Li Bassi, Lenias Hwenda
The Lancet. Global Health|June 18, 2022
The African Medicines Agency: the key to unlocking clinical research in AfricaLenias Hwenda, Michel Sidibe, Michael Makanga
The New England Journal of Medicine|December 23, 2011
Stemming the brain drain--a WHO global code of practice on international recruitment of health personnelAllyn L Taylor, Lenias Hwenda, Bjørn-Inge Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitisHui-Rong Jiang, Lenias Hwenda, Kimmo Makinen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
Frontiers in Pharmacology|October 19, 2020
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the FutureOlayinka O Ogunleye, Debashis Basu, Debjani Mueller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Lancet. Global Health|June 17, 2022
The business case for vaccine and drug manufacturing in middle-income countriesLenias Hwenda
Lancet (London, England)|November 15, 2011
The remaining smallpox stocks: the wrong debate?Lenias Hwenda, Bjørn-Inge Larsen
The Lancet. Global Health|April 20, 2020
COVID-19: time to plan for prompt universal access to diagnostics and treatmentsLuca Li Bassi, Lenias Hwenda
The Lancet. Global Health|June 18, 2022
The African Medicines Agency: the key to unlocking clinical research in AfricaLenias Hwenda, Michel Sidibe, Michael Makanga
The New England Journal of Medicine|December 23, 2011
Stemming the brain drain--a WHO global code of practice on international recruitment of health personnelAllyn L Taylor, Lenias Hwenda, Bjørn-Inge Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitisHui-Rong Jiang, Lenias Hwenda, Kimmo Makinen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
Frontiers in Pharmacology|October 19, 2020
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the FutureOlayinka O Ogunleye, Debashis Basu, Debjani Mueller, et al.
Pageof 1